Evidence map›Paper›PMID 31038548›Full record

ArticleMemorias do Instituto Oswaldo Cruz2019

Resistance to temephos and deltamethrin in Aedes aegypti from Brazil between 1985 and 2017.

Denise Valle, Diogo Fernandes Bellinato, Priscila Fernandes Viana-Medeiros, José Bento Pereira Lima, Ademir de Jesus Martins Junior

Open access · diamondAbstract read
In one paragraph

Article in Memorias do Instituto Oswaldo Cruz, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
17.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 156 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Molecules (Basel, Switzerland) · 2025
    Article
  14. Article
  15. Genotoxicity of dillapioleToxicology reports · 2024
    Article
  16. Organophosphate and Pyrethroid Resistance Status of InvasiveJournal of arthropod-borne diseases · 2024
    Article
  17. Article
  18. Article
  19. High Frequencies ofPathogens (Basel, Switzerland) · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Denise ValleFundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Biologia Molecular de Flavivírus, Rio de Janeiro, RJ, Brasil.ORCID http://orcid.org/0000-0003-4148-274X
Diogo Fernandes BellinatoFundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Biologia Molecular de Flavivírus, Rio de Janeiro, RJ, Brasil.
Priscila Fernandes Viana-MedeirosFundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Biologia Molecular de Flavivírus, Rio de Janeiro, RJ, Brasil.
José Bento Pereira LimaFundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Fisiologia e Controle de Artrópodes Vetores, Rio de Janeiro, RJ, Brasil.
Ademir de Jesus Martins JuniorFundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Fisiologia e Controle de Artrópodes Vetores, Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz · BRInstituto de Biologia do Exército · BRInstituto Nacional de Ciência e Tecnologia em Entomologia Molecular · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAedes aegypti populations in Brazil have been subjected to insecticide selection pressures with variable levels and sources since 1967. Therefore, the Brazilian Ministry of Health (MoH) coordinated the activities of an Ae. aegypti insecticide resistance monitoring network (MoReNAa) from 1999 to 2012.

objectivesThe objective of this study was to consolidate all information available from between 1985 and 2017 regarding the resistance status and mechanisms of Brazilian Ae. aegypti populations against the main insecticide compounds used at the national level, including the larvicide temephos (an organophosphate) and the adulticide deltamethrin (a pyrethroid).

methodsData were gathered from two sources: a bibliographic review of studies published from 1985 to 2017, and unpublished data produced by our team within the MoReNAa between 1998 and 2012. A total of 146 municipalities were included, many of which were evaluated several times, totalling 457 evaluations for temephos and 274 for deltamethrin. Insecticide resistance data from the five Brazilian regions were examined separately using annual records of both the MoH supply of insecticides to each state and the dengue incidence in each evaluated municipality.

findingsAe. aegypti resistance to temephos and deltamethrin, the main larvicide and adulticide, respectively, employed against mosquitoes in Brazil for a long time, was found to be widespread in the country, although with some regional variations. Comparisons between metabolic and target-site resistance mechanisms showed that one or another of these was the main component of pesticide resistance in each studied population. MAIN

conclusions(i) A robust dataset on the assessments of the insecticide resistance of Brazilian Ae. aegypti populations performed since 1985 was made available through our study. (ii) Our findings call into question the efficacy of chemical control as the sole methodology of vector control. (iii) It is necessary to ensure that sustainable insecticide resistance monitoring is maintained as a key component of integrated vector management. (iv) Consideration of additional parameters, beyond the supply of insecticides distributed by the MoH or the diverse local dynamics of dengue incidence, is necessary to find consistent correlations with heterogeneous vector resistance profiles.

Indexed as

AedesAnimalsBiological AssayBrazilDengueIncidenceInsecticide ResistanceInsecticidesMosquito VectorsNitrilesPyrethrinsTemefosdecamethrinInsecticidesNitrilesPyrethrinsTemefos

Identifiers

PMID31038548
PMCPMC6489372
OpenAlexW2942769658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.